Journal article icon

Journal article

Involvement of propranolol in suicides: cross-sectional study using coroner-reported data

Abstract:
Background: Propranolol is a beta-blocker medication indicated mostly for heart rhythm conditions and for physical symptoms of anxiety. Prescriptions for propranolol in the UK have increased since 2008. Recently, there have been concerns about the involvement of propranolol in intentional poisonings, but such deaths are not routinely reported. Therefore, use of coroner-reported and toxicology data enables unique investigation into the scale of involvement of propranolol in suicide. Aims: To describe the extent to which propranolol is involved in suicides, including patterns over time and characteristics of people whose suicide involved propranolol compared with other suicides. Method: Data were derived from the National Programme on Substance Use Mortality (NPSUM). All suicides and deaths of undetermined intent between 2010 and 2021 in England, Wales and Northern Ireland were extracted, and a subset was identified where propranolol was involved in death. Results: There were 4473 suicides of which 297 (6.6%) involved propranolol, with the proportion involving propranolol nearly quadrupling during the study period (3.4% v. 12.3%). Compared with all other suicides, a greater proportion of propranolol suicides were in women (56.6% v. 37.1%) and in people with diagnoses of depression (39.1% v. 27.1%) and anxiety (22.2% v. 8.6%). When suicide involved propranolol, an antidepressant was detected at post-mortem in 81.8% of deaths, most commonly a selective serotonin reuptake inhibitor (SSRIs) (51.5%), and most often citalopram (24.6%). Conclusions: A small number, but increasing proportion, of suicides reported to the NPSUM involve propranolol. Vigilance to the combined toxicity profile of medicines used alongside propranolol may be pertinent
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1192/bjo.2024.714

Authors

More by this author
Role:
Author
ORCID:
0000-0001-5017-9174
More by this author
Role:
Author
ORCID:
0000-0003-4762-2950
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0002-5437-5962
More by this author
Role:
Author
ORCID:
0000-0002-4462-1402


Publisher:
Cambridge University Press
Journal:
BJPsych Open More from this journal
Volume:
10
Issue:
4
Pages:
e127-e127
Publication date:
2024-06-03
DOI:
EISSN:
2056-4724
ISSN:
2056-4724


Language:
English
Keywords:
Pubs id:
2380861
Local pid:
pubs:2380861
Source identifiers:
W4399299873
Deposit date:
2026-02-24
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP